XJPX6197
Market cap280mUSD
Jan 22, Last price
476.00JPY
1D
0.21%
1Q
-2.86%
Jan 2017
18.60%
IPO
21.53%
Name
Solasto Corp
Chart & Performance
Profile
Solasto Corporation provides medical outsourcing services primarily to medical institutions in Japan. The company's medical outsourcing services include contracted services of medical clerical work. It also offers elderly care services, such as day service, home help, facility-based service, etc.; and childcare services, as well as engages in the education business. The company was formerly known as N.I.C Corporation. Solasto Corporation was founded in 1965 and is headquartered in Tokyo, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | 2016‑03 | 2015‑03 | |
Income | ||||||||||
Revenues | 135,139,000 3.09% | 131,088,000 11.81% | 117,239,000 10.41% | |||||||
Cost of revenue | 113,205,000 | 109,335,000 | 96,775,000 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 21,934,000 | 21,753,000 | 20,464,000 | |||||||
NOPBT Margin | 16.23% | 16.59% | 17.45% | |||||||
Operating Taxes | 1,884,000 | 2,245,000 | 2,138,000 | |||||||
Tax Rate | 8.59% | 10.32% | 10.45% | |||||||
NOPAT | 20,050,000 | 19,508,000 | 18,326,000 | |||||||
Net income | 2,257,000 -28.85% | 3,172,000 -9.42% | 3,502,000 -1.02% | |||||||
Dividends | (1,886,000) | (1,891,000) | (1,888,000) | |||||||
Dividend yield | 3.65% | 3.15% | 2.02% | |||||||
Proceeds from repurchase of equity | (1,518,000) | 9,848,000 | ||||||||
BB yield | 2.94% | -10.54% | ||||||||
Debt | ||||||||||
Debt current | 5,282,000 | 4,182,000 | 9,437,000 | |||||||
Long-term debt | 26,524,000 | 25,133,000 | 22,803,000 | |||||||
Deferred revenue | 7,000 | 3,718,000 | 2,741,000 | |||||||
Other long-term liabilities | 5,781,000 | 1,664,000 | 1,931,000 | |||||||
Net debt | 16,273,000 | 11,618,000 | 16,631,000 | |||||||
Cash flow | ||||||||||
Cash from operating activities | 7,858,000 | 9,012,000 | 5,519,000 | |||||||
CAPEX | (1,218,000) | (1,324,000) | (798,000) | |||||||
Cash from investing activities | (2,762,000) | (2,171,000) | (7,446,000) | |||||||
Cash from financing activities | (1,837,000) | (5,211,000) | 3,201,000 | |||||||
FCF | 19,752,000 | 20,598,000 | 14,480,000 | |||||||
Balance | ||||||||||
Cash | 15,115,000 | 11,957,000 | 10,340,000 | |||||||
Long term investments | 418,000 | 5,740,000 | 5,269,000 | |||||||
Excess cash | 8,776,050 | 11,142,600 | 9,747,050 | |||||||
Stockholders' equity | 16,397,000 | 37,487,000 | 34,756,000 | |||||||
Invested Capital | 46,002,950 | 38,743,400 | 40,773,950 | |||||||
ROIC | 47.32% | 49.07% | 49.46% | |||||||
ROCE | 39.24% | 42.91% | 39.87% | |||||||
EV | ||||||||||
Common stock shares outstanding | 93,662 | 94,627 | 94,598 | |||||||
Price | 551.00 -13.09% | 634.00 -35.83% | 988.00 -30.81% | |||||||
Market cap | 51,607,856 -13.98% | 59,993,273 -35.81% | 93,462,345 -30.79% | |||||||
EV | 67,880,856 | 93,086,273 | 130,232,345 | |||||||
EBITDA | 25,272,000 | 24,888,000 | 23,061,000 | |||||||
EV/EBITDA | 2.69 | 3.74 | 5.65 | |||||||
Interest | 288,000 | 272,000 | 237,000 | |||||||
Interest/NOPBT | 1.31% | 1.25% | 1.16% |